Sugi Predict

Sugi Predict / Compounds / SCHEMBL2819316

SCHEMBL2819316

SCHEMBL2819316

CC1(C)CC(=O)c2ccccc2C1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ POLB P06746 1/20 0.37
▸ MAPT P10636 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HBB P68871 1/20 0.37
▸ BUB1 O43683 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ IDO1 P14902 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ CYP11B1 P15538 2/20 0.34
▸ CYP11B2 P19099 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806167 0.84 MEN1 (0.41) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL2817660 0.74 ALDH1A1 (0.47) MEN1KMT2APOLBMAPTKDM4E
SCHEMBL2817748 0.74 POLB (0.53) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL1745011 0.73 ALOX15 (0.44) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL14429883 0.73 ALOX15 (0.44) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL1098201 0.72 ALDH1A1 (0.40) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL30884927 0.70 ALDH1A1 (0.39) MEN1KMT2APOLBMAPTKDM4E
SCHEMBL13952089 0.70 ALDH1A1 (0.36) MEN1KMT2APOLBMAPTKDM4E
SCHEMBL25834640 0.69 CYP2D6 (0.39) MEN1KMT2APOLBMAPTALDH1A1
SCHEMBL19302757 0.69 AR (0.46) MAPTKDM4EALDH1A1MAPK1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536224-B2 Pharmaceutical and nutraceutical compositions of abscisic acid VALENT BIOSCIENCES CORPORATION (US) 2013-09-17 — — US disclosed
US-8436035-B2 Organic compounds NOVARTIS AG (CH) 2013-05-07 — — US disclosed
US-8436035-B2 Organic compounds NOVARTIS AG (CH) 2013-05-07 — — US disclosed
US-8436035-B2 Organic compounds NOVARTIS AG (CH) 2013-05-07 — — US disclosed
EP-2213668-A2 Imidazoles as aldosterone synthase inhibitors Novartis AG (CH) 2010-08-04 — — EP disclosed
US-20100048562-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-02-25 — — US disclosed
US-20100048562-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2010-02-25 — — US disclosed
EP-2094680-A2 IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS Novartis AG (CH) 2009-09-02 — — EP disclosed
WO-2008076336-A2 IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2008-06-26 — — WO disclosed
WO-2008076336-A2 IMIDAZOLES AS ALDOSTERONE SYNTHASE INHIBITORS NOVARTIS AG (CH) 2008-06-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048562-A1 ORGANIC COMPOUNDS CYP11B1, HSD11B1, CYP17A1 MEN1 4309/4885KMT2A 3271/4885POLB 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.